a66d97289f7e5570ea126da85384204c

CÁNULA GUEDEL - OROPHARYNGE AL AIRWAYS - CÁNULA GUEDEL

GUEDEL CANNULA - OROPHARYNGE AL AIRWAYS - GUEDEL CANNULA
MEDITEC S.A.·I·Colombia INVIMA·Expires December 24, 2030
Device classification
Risk class / Clase de Riesgo
I
Product type (Spanish)
MEDICO QUIRURGICOS
Product type (English)
SURGICAL DOCTOR
Registration information
Analysis ID
a66d97289f7e5570ea126da85384204c
Expire date
December 24, 2030
Authorized company / Fabricante
Name (Spanish)
MEDITEC S.A.
Name (English)
MEDITEC S.A.
Product use / Uso del Producto
Spanish

EL TUBO OROFARÍNGEO O CÁNULA GUEDEL MANTIENE LA VÍA AÉREA PERMEABLE INTRODUCIENDOLO POR LA BOCA. SE UTILIZA PARA LA ADMINISTRACIÓN DE OXÍGENO Y GASES ANESTÉSICOS A LOS PACIENTES, TAMBIÉN ES USADO PARA EVITAR QUE LOS PACIENTES SE LASTIMEN LA LENGUA CUANDO DESPIERTEN DESPUÉS DE LA OPERACIÓN CON ANESTESIA GENERAL. _x000D_ _x000D_ _x000D_

English

THE OROPHARYNGEAL TUBE OR GUEDEL CANNULA KEEPS THE AIRWAY PERMEABLE BY INTRODUCING IT THROUGH THE MOUTH. IT IS USED FOR THE ADMINISTRATION OF OXYGEN AND ANESTHETIC GASES TO PATIENTS, IT IS ALSO USED TO PREVENT PATIENTS FROM INJURING THEIR TONGUE WHEN THEY WAKE UP AFTER THE OPERATION UNDER GENERAL ANESTHESIA. _x000D_ _x000D_ _x000D_

About this record

Access comprehensive regulatory information for CÁNULA GUEDEL - OROPHARYNGE AL AIRWAYS - CÁNULA GUEDEL (GUEDEL CANNULA - OROPHARYNGE AL AIRWAYS - GUEDEL CANNULA) in the Colombia medical device market through Pure Global AI's free database. This I medical device is registered under INVIMA analysis ID a66d97289f7e5570ea126da85384204c and manufactured by MEDITEC S.A.. The device was registered on December 24, 2030.

This page provides complete registration details including product type (SURGICAL DOCTOR), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.